ProPhase Labs Inc
NASDAQ:PRPH 4:00:00 PM EDT
| Market Cap (Intraday) | 98.16M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 5.98 |
| 10-Day MA | $6.29 |
| 50-Day MA | $5.52 |
| 200-Day MA | $5.24 |
ProPhase Labs Inc Stock, NASDAQ:PRPH
711 Stewart Avenue, Suite 200, Garden City, New York 11530
United States of America
Phone: +1.215.345.0919
Number of Employees: 113
Description
ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements. It operates through the Diagnostic Services and Consumer Products segment. The Diagnostic Services segment includes COVID-19 and other diagnostic testing services. The Consumer Products segment consists of the manufacturing, retail customers, and personal genomics products and services. The company was founded by Guy J. Quigley and Charles A. Phillips in July 1989 and is headquartered in Garden City, NY.